Pentokey Organy India Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
46.70 +1.66 (3.69%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
43.21
Today’s High
46.7
52 Week Low
38
52 Week High
129.75
Key Metrics
- Market Cap (In Cr) 28.25
- Beta 0.4
- Div. Yield (%) 0
- P/B 3.05
- TTM P/E 145.5
- Peg Ratio 5.23
- Sector P/E 0
- D/E 0
- Open Price 43.21
- Prev Close 45.04
Pentokey Organy India Analysis
Price Analysis
-
1 Week-4.19%
-
3 Months-12.08%
-
6 Month13.97%
-
YTD-55.75%
-
1 Year-16.59%
Risk Meter
- 65% Low risk
- 65% Moderate risk
- 65% Balanced Risk
- 65% High risk
- 65% Extreme risk
Pentokey Organy India Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 4.4
- Selling/ General/ Admin Expenses Total
- 0.14
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.37
- Total Operating Expense
- 3.97
- Operating Income
- 0.43
- Net Income Before Taxes
- 0.87
- Net Income
- 0.87
- Diluted Normalized EPS
- 1.39
- Period
- 2024
- Total Assets
- 9.51
- Total Liabilities
- 0.24
- Total Equity
- 9.26
- Tangible Book Valueper Share Common Eq
- 14.77
- Period
- 2024
- Cashfrom Operating Activities
- 0.55
- Cashfrom Investing Activities
- -0.59
- Cashfrom Financing Activities
- -0.01
- Net Changein Cash
- -0.04
- Period
- 2023
- Total Revenue
- 4.37
- Selling/ General/ Admin Expenses Total
- 0.14
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.17
- Total Operating Expense
- 3.52
- Operating Income
- 0.85
- Net Income Before Taxes
- 3.18
- Net Income
- 3.18
- Diluted Normalized EPS
- 5.06
- Period
- 2023
- Total Assets
- 8.92
- Total Liabilities
- 0.54
- Total Equity
- 8.38
- Tangible Book Valueper Share Common Eq
- 13.36
- Period
- 2023
- Cashfrom Operating Activities
- -0.1
- Cashfrom Investing Activities
- 0.19
- Cashfrom Financing Activities
- -0.03
- Net Changein Cash
- 0.06
- Period
- 2022
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.15
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.23
- Total Operating Expense
- 0.39
- Operating Income
- -0.39
- Net Income Before Taxes
- -0.16
- Net Income
- -0.16
- Diluted Normalized EPS
- -0.26
- Period
- 2022
- Total Assets
- 5.25
- Total Liabilities
- 0.05
- Total Equity
- 5.2
- Tangible Book Valueper Share Common Eq
- 8.29
- Period
- 2022
- Cashfrom Operating Activities
- -0.42
- Cashfrom Investing Activities
- 0.23
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.19
- Period
- 2021
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.2
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.32
- Total Operating Expense
- 0.53
- Operating Income
- -0.53
- Net Income Before Taxes
- -0.24
- Net Income
- -0.24
- Diluted Normalized EPS
- -0.38
- Period
- 2021
- Total Assets
- 5.51
- Total Liabilities
- 0.15
- Total Equity
- 5.36
- Tangible Book Valueper Share Common Eq
- 8.54
- Period
- 2021
- Cashfrom Operating Activities
- 0.56
- Cashfrom Investing Activities
- -0.55
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.01
- Period
- 2020
- Total Revenue
- 1.56
- Selling/ General/ Admin Expenses Total
- 0.19
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.56
- Total Operating Expense
- 2.25
- Operating Income
- -0.69
- Net Income Before Taxes
- -0.44
- Net Income
- -0.44
- Diluted Normalized EPS
- -0.7
- Period
- 2020
- Total Assets
- 6.09
- Total Liabilities
- 0.5
- Total Equity
- 5.59
- Tangible Book Valueper Share Common Eq
- 8.91
- Period
- 2020
- Cashfrom Operating Activities
- 0.86
- Cashfrom Investing Activities
- -0.89
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.03
- Period
- 2019
- Total Revenue
- 9.29
- Selling/ General/ Admin Expenses Total
- 0.19
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.74
- Total Operating Expense
- 10.14
- Operating Income
- -0.85
- Net Income Before Taxes
- 0.31
- Net Income
- 0.31
- Diluted Normalized EPS
- -0.51
- Period
- 2019
- Total Assets
- 6.91
- Total Liabilities
- 0.88
- Total Equity
- 6.04
- Tangible Book Valueper Share Common Eq
- 9.62
- Period
- 2019
- Cashfrom Operating Activities
- -1.95
- Cashfrom Investing Activities
- 1.7
- Cashfrom Financing Activities
- -0.01
- Net Changein Cash
- -0.25
- Period
- 2018
- Total Revenue
- 4.7
- Selling/ General/ Admin Expenses Total
- 0.19
- Depreciation/ Amortization
- 0.06
- Other Operating Expenses Total
- 0.81
- Total Operating Expense
- 5.38
- Operating Income
- -0.68
- Net Income Before Taxes
- 0.05
- Net Income
- 0.01
- Diluted Normalized EPS
- -0.81
- Period
- 2018
- Total Assets
- 6.19
- Total Liabilities
- 0.46
- Total Equity
- 5.72
- Tangible Book Valueper Share Common Eq
- 9.12
- Period
- 2018
- Cashfrom Operating Activities
- 8.31
- Cashfrom Investing Activities
- -0.61
- Cashfrom Financing Activities
- -7.29
- Net Changein Cash
- 0.42
- Period
- 2024-09-29
- Total Revenue
- 0.22
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 0.26
- Operating Income
- -0.04
- Net Income Before Taxes
- 0.11
- Net Income
- 0.11
- Diluted Normalized EPS
- 0.17
- Period
- 2024-09-29
- Total Assets
- 9.7
- Total Liabilities
- 0.29
- Total Equity
- 9.42
- Tangible Book Valueper Share Common Eq
- 15.01
- Period
- 2024-09-29
- Cashfrom Operating Activities
- 0.26
- Cashfrom Investing Activities
- -0.26
- Cashfrom Financing Activities
- -0
- Net Changein Cash
- -0.01
- Period
- 2024-06-30
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 0.08
- Operating Income
- -0.08
- Net Income Before Taxes
- 0.05
- Net Income
- 0.05
- Diluted Normalized EPS
- 0.07
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.04
- Total Operating Expense
- 0.07
- Operating Income
- -0.07
- Net Income Before Taxes
- 0.05
- Net Income
- 0.05
- Diluted Normalized EPS
- 0.08
- Period
- 2024-03-31
- Total Assets
- 9.51
- Total Liabilities
- 0.24
- Total Equity
- 9.26
- Tangible Book Valueper Share Common Eq
- 14.77
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 0.55
- Cashfrom Investing Activities
- -0.59
- Cashfrom Financing Activities
- -0.01
- Net Changein Cash
- -0.04
- Period
- 2023-12-31
- Total Revenue
- 0.03
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 0.1
- Operating Income
- -0.07
- Net Income Before Taxes
- 0.04
- Net Income
- 0.04
- Diluted Normalized EPS
- 0.06
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 2.07
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.2
- Total Operating Expense
- 1.82
- Operating Income
- 0.24
- Net Income Before Taxes
- 0.36
- Net Income
- 0.36
- Diluted Normalized EPS
- 0.57
- Period
- 2023-09-30
- Total Assets
- 9.87
- Total Liabilities
- 0.71
- Total Equity
- 9.17
- Tangible Book Valueper Share Common Eq
- 14.61
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -0.25
- Cashfrom Investing Activities
- 0.24
- Cashfrom Financing Activities
- -0.01
- Net Changein Cash
- -0.01
- Period
- 2023-06-30
- Total Revenue
- 2.3
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.11
- Total Operating Expense
- 1.97
- Operating Income
- 0.32
- Net Income Before Taxes
- 0.43
- Net Income
- 0.43
- Diluted Normalized EPS
- 0.68
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 0.61
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 0.49
- Operating Income
- 0.12
- Net Income Before Taxes
- 0.2
- Net Income
- 0.2
- Diluted Normalized EPS
- 0.31
- Period
- 2023-03-31
- Total Assets
- 8.92
- Total Liabilities
- 0.54
- Total Equity
- 8.38
- Tangible Book Valueper Share Common Eq
- 13.36
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -0.1
- Cashfrom Investing Activities
- 0.19
- Cashfrom Financing Activities
- -0.03
- Net Changein Cash
- 0.06
- Period
- 2022-12-31
- Total Revenue
- 2.32
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.05
- Total Operating Expense
- 1.56
- Operating Income
- 0.76
- Net Income Before Taxes
- 2.88
- Net Income
- 2.88
- Diluted Normalized EPS
- 4.6
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Pentokey Organy India Technical
Moving Average
SMA
- 5 Day48.09
- 10 Day49.38
- 20 Day49.43
- 50 Day51.99
- 100 Day50.68
- 300 Day53.91
Pentokey Organy India Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Venlon Enterprises
- 6.35
- -0.26
- -3.93
- 9.74
- 4.15
- 33.17
- Dynamic Industries
- 105
- -0.9
- -0.85
- 124.2
- 58.07
- 31.8
- Pentokey Organy India
- 46.7
- 1.66
- 3.69
- 129.75
- 38
- 29.29
- Ritesh International
- 30.09
- -1.06
- -3.4
- 40.25
- 22.41
- 25.74
- Jayshree Chemicals
- 8.92
- -0.05
- -0.56
- 13.75
- 7.79
- 26.16
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Venlon Enterprises
- -
- -
- -
- -226.61
- Dynamic Industries
- -
- 0.69
- 1.59
- 1.61
- Pentokey Organy India
- 32.38
- 3.05
- 9.95
- 31.03
- Ritesh International
- 934.87
- 1.38
- 8.6
- 1.47
- Jayshree Chemicals
- -
- 2.52
- -6.87
- -17.02
Pentokey Organy India Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 09-Nov-24
- Quarterly Results
- 10-Aug-24
- Quarterly Results
- 13-May-24
- Audited Results
- 09-Nov-23
- Quarterly Results
- 12-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results
- 21-Jan-23
- Quarterly Results
- 08-Nov-22
- Quarterly Results
- 02-Aug-22
- Quarterly Results & A.G.M.
- 21-May-22
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 28-Sept-24
- 12-Aug-24
- AGM
- 29-Sept-23
- 15-Sept-23
- AGM
- 28-Sept-21
- 12-Aug-21
- AGM